Introducing the symposium,Tony Moffat,from the School of Pharmacy,University of London,emphasised the importance of recognising that quality for a pharmaceutical product must be built in at the start of the manufacturing process.Speakers addressed the subject of how the solid form of a pure ingredient should be selected.Jim McCabe,of AstraZeneca,explained that once a pharmacological entity has been chosen for development.
展开▼
